Tang Capital
View Older Stories View More Recent Stories
-
Form SC 13G Cellectar Biosciences, Filed by: TANG CAPITAL PARTNERS LP
-
BioTime Announces Appointment of General Counsel
-
Form 13F-HR TANG CAPITAL MANAGEMENT For: Mar 31
-
Form SC 13D/A Odonate Therapeutics, Filed by: TANG CAPITAL PARTNERS LP
-
Form 4 Odonate Therapeutics, For: Mar 07 Filed by: TANG CAPITAL PARTNERS LP
-
Form 13F-HR TANG CAPITAL MANAGEMENT For: Dec 31
-
Form SC 13G/A ROCKET PHARMACEUTICALS, Filed by: TANG CAPITAL PARTNERS LP
-
Attune Pharmaceuticals Announces $23M Series B Financing to Advance ATN-249 for the Treatment of HAE
-
Form SC 13D/A LA JOLLA PHARMACEUTICAL Filed by: TANG CAPITAL PARTNERS LP
-
Form 4 Odonate Therapeutics, For: Nov 27 Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form 4 Odonate Therapeutics, For: Nov 21 Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form 13F-HR TANG CAPITAL MANAGEMENT For: Sep 30
-
Form SC 13D/A Odonate Therapeutics, Filed by: TANG CAPITAL PARTNERS LP
-
Form 4 Odonate Therapeutics, For: Oct 26 Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form 4 Odonate Therapeutics, For: Oct 23 Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form 4 Odonate Therapeutics, For: Sep 27 Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form 4 Odonate Therapeutics, For: Sep 24 Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form SC 13D/A HERON THERAPEUTICS, INC. Filed by: TANG CAPITAL PARTNERS LP
-
Form 4 HERON THERAPEUTICS, INC. For: Sep 12 Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form SC 13D/A Odonate Therapeutics, Filed by: TANG CAPITAL PARTNERS LP
-
Form 4 Odonate Therapeutics, For: Aug 21 Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form 4 Odonate Therapeutics, For: Aug 16 Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form 4 Odonate Therapeutics, For: Aug 13 Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form 13F-HR TANG CAPITAL MANAGEMENT For: Jun 30
-
Form 13F-HR TANG CAPITAL MANAGEMENT For: Mar 31
-
Crypto Asset Management Welcomes Two New Executive Officers
-
Form SC 13D/A LA JOLLA PHARMACEUTICAL Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13D/A LA JOLLA PHARMACEUTICAL Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G/A Ignyta, Inc. Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G/A Ignyta, Inc. Filed by: TANG CAPITAL PARTNERS LP
-
Form 13F-HR TANG CAPITAL MANAGEMENT For: Dec 31
-
Form SC 13G ROCKET PHARMACEUTICALS, Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13D Odonate Therapeutics, Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13D/A Cyclacel Pharmaceuticals Filed by: TANG CAPITAL PARTNERS LP
-
AVEO Announces Appointment of Nikhil Mehta, Ph.D., as Senior Vice President of Regulatory and Quality Assurance
-
Form 13F-HR TANG CAPITAL MANAGEMENT For: Sep 30
-
Form 13F-HR TANG CAPITAL MANAGEMENT For: Jun 30
-
Form 13F-HR TANG CAPITAL MANAGEMENT For: Mar 31
-
Form SC 13D/A LA JOLLA PHARMACEUTICAL Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13D/A Cyclacel Pharmaceuticals Filed by: TANG CAPITAL PARTNERS LP
-
Form 13F-HR TANG CAPITAL MANAGEMENT For: Dec 31
-
Form SC 13D/A HERON THERAPEUTICS, INC. Filed by: TANG CAPITAL PARTNERS LP
-
Form 13F-HR TANG CAPITAL MANAGEMENT For: Sep 30
-
Form SC 13D Cyclacel Pharmaceuticals Filed by: TANG CAPITAL PARTNERS LP
-
Unusual 11 Mid-Day Movers 8/22: (RLJE) (CIFC) (CYCC) Higher; (DRD) (PRTS) (XTNT) Lower
-
Cyclacel Pharma (CYCC) Shares Trade Strong Following Tang Capital 13G Filing
-
Form SC 13G Cyclacel Pharmaceuticals Filed by: TANG CAPITAL PARTNERS LP
-
Form 13F-HR TANG CAPITAL MANAGEMENT For: Jun 30
-
Form SC 13D/A HERON THERAPEUTICS, INC. Filed by: TANG CAPITAL PARTNERS LP
-
Heron Therapeutics Reports Second Quarter 2016 Financial Results and Recent Corporate Progress

